Genipin improves obesity through promoting bile secretion and changing bile acids composition in diet-induced obese rats.
J Pharm Pharmacol
; 76(7): 897-907, 2024 Jul 05.
Article
in En
| MEDLINE
| ID: mdl-38727186
ABSTRACT
OBJECTIVES:
Bile acids (BAs), as signaling molecules to regulate metabolism, have received considerable attention. Genipin is an iridoid compound extracted from Fructus Gradeniae, which has been shown to relieve adiposity and metabolic syndrome. Here, we investigated the mechanism of genipin counteracting obesity and its relationship with BAs signals in diet-induced obese (DIO) rats.METHODS:
The DIO rats were received intraperitoneal injections of genipin for 10 days. The body weight, visceral fat, lipid metabolism in the liver, thermogenic genes expressions in brown fat, BAs metabolism and signals, and key enzymes for BAs synthesis were determined. KEYFINDINGS:
Genipin inhibited fat synthesis and promoted lipolysis in the liver, and upregulated thermogenic gene expressions in brown adipose tissue of DIO rats. Genipin increased bile flow rate and upregulated the expressions of aquaporin 8 and the transporters of BAs in liver. Furthermore, genipin changed BAs composition by promoting alternative pathways and inhibiting classical pathways for BAs synthesis and upregulated the expressions of bile acid receptors synchronously.CONCLUSIONS:
These results suggest that genipin ameliorate obesity through BAs-mediated signaling pathways.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bile Acids and Salts
/
Rats, Sprague-Dawley
/
Iridoids
/
Liver
/
Obesity
Limits:
Animals
Language:
En
Journal:
J Pharm Pharmacol
Year:
2024
Document type:
Article
Affiliation country:
China